Orteronel in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer

Clinical trial NCT01866423 · TERMINATED

Trial details

NCT number: NCT01866423
Sponsor: University of Southern California
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Adenocarcinoma of the Prostate Hormone-resistant Prostate Cancer Recurrent Prostate Cancer Stage IV Prostate Cancer

Start date: 2013-10-25
Primary completion: 2015-07-23
Enrollment: 4

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.